The Food and Drug Administration (FDA) has officially launched the eSUMBONG system, a new online reporting mechanism integrated into its updated website.
This initiative marks a significant advancement in regulatory enforcement, providing the public with a streamlined and secure channel to lodge complaints or report violations concerning FDA-regulated products.
By centralizing complaint submissions, the FDA aims to strengthen transparency, accountability, and responsiveness in safeguarding public health.
Read the full advisory here: https://www.fda.gov.ph/wp-content/uploads/2026/05/FDA-ADVISORY-NO.2026-0594-20260414080502.pdf
Purpose of the Advisory
To announce the official launch of the eSUMBONG system within the new FDA website.
To provide guidelines on the use of the system as the official online reporting platform for complaints and reports involving FDA-regulated products, establishments, and related concerns.
Scope of Application
This advisory applies to consumers, manufacturers, distributors, healthcare providers, regulatory stakeholders, and the public who wish to report complaints or violations concerning FDA-regulated products and establishments.
Key Features of eSUMBONG Scope of Complaints
The eSUMBONG system accepts reports under the following categories:
- Counterfeit and violative health products
- Unlicensed establishments
- Anti-corruption complaints involving FDA personnel
Application-related complaints, including procedural errors, systemic issues, or delays beyond Citizen’s Charter timelines
- Product-related complaints, including adverse reactions, quality issues, or safety issues
Important Limitation
- The eSUMBONG system is not a portal for general inquiries or follow-ups.
- Submissions related to inquiries or application tracking will be automatically dismissed.
Proper Channels for Other Concerns
- Application status tracking: FDA eServices / ePortal / FDA kiosks
- General inquiries: info@fda.gov.ph
Discontinuation of Previous Reporting Channels
- Effective immediately, the former eReport scheme and related email addresses are discontinued.
- The eSUMBONG system is now the sole official reporting platform for covered complaints.
Submission Process
- Reporters receive an automated acknowledgment email with a unique reference number.
- Subsequent confirmation is issued by the concerned FDA Center or Office, including an internal Document Tracking Number (DTN).
Flowchart Process of eSUMBONG
Implications to Clients
The eSUMBONG system carries significant implications for various stakeholders.
- Consumers gain a direct and reliable avenue to report suspicious products, reinforcing their role in protecting public health.
- Manufacturers and distributors may face increased scrutiny, encouraging stricter compliance with regulatory standards.
- Regulatory staff will benefit from streamlined workflows, enabling faster case management and enforcement actions.
- The system fosters greater accountability across the supply chain, ensuring that violations are promptly reported and investigated.
Effective Date
Effective immediately
For Inquiries
For inquiries or support regarding medical device regulatory requirements in the Philippines, please contact sales@andamanmed.com.